PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274 | +18.1% | 8,940 | +46.3% | 0.02% | +10.5% |
| Q2 2023 | $232 | -6.8% | 6,110 | 0.0% | 0.02% | -5.0% |
| Q1 2023 | $249 | +5.5% | 6,110 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $236 | -99.9% | 6,110 | 0.0% | 0.02% | -33.3% |
| Q3 2022 | $325,000 | +38.3% | 6,110 | +51.6% | 0.03% | +42.9% |
| Q2 2022 | $235,000 | -23.7% | 4,030 | 0.0% | 0.02% | -12.5% |
| Q1 2022 | $308,000 | +8.1% | 4,030 | -14.3% | 0.02% | +4.3% |
| Q2 2021 | $285,000 | -13.4% | 4,700 | 0.0% | 0.02% | -23.3% |
| Q1 2021 | $329,000 | +8.6% | 4,700 | -31.9% | 0.03% | -16.7% |
| Q2 2020 | $303,000 | +31.2% | 6,900 | 0.0% | 0.04% | +9.1% |
| Q1 2020 | $231,000 | -26.2% | 6,900 | 0.0% | 0.03% | -29.8% |
| Q4 2019 | $313,000 | – | 6,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |